Diality

Diality, founded in 2018 and based in Irvine, California, is a private medical device company developing the Moda-flx Hemodialysis System. The platform received FDA clearance for professional care settings in August 2024 and is currently undergoing a home-use clinical trial (PRESCRIBE Diality) under an IDE. The company aims to address the burden of dialysis care by offering a versatile, easy-to-use system that supports personalized prescriptions and data-driven decision-making, targeting both clinic and home hemodialysis markets.

The Moda-flx Hemodialysis System, an integrated platform featuring clinical flexibility for multiple dialysis modalities, a built-in reverse osmosis water filtration system, an intuitive user interface for shortened training, cloud-based data storage/analytics, and a mobile cart design.

Diality competes in the hemodialysis machine market dominated by global giants Fresenius Medical Care and Baxter. Its primary differentiation is the integrated water system and design for multi-setting flexibility, particularly for the home. It also competes with other niche and emerging players aiming to modernize dialysis technology and tap into the home market.